Department of internal medicine Douala General Hospital Cameroon Faculty of medicine and pharmaceutical science, University of Douala, Douala, Cameroon.
Non-Communicable Diseases Research Unit, South African Medical Research Council, Cape Town, South Africa.
BMC Nephrol. 2020 Mar 18;21(1):101. doi: 10.1186/s12882-020-01760-6.
Little is known about the changes in disease makers and risk factors in patients with chronic kidney disease (CKD) under nephrological care in Africa. This study aimed to evaluate the baseline level of markers of CKD and their 12-month time-trend in newly referred patients in a tertiary hospital in Cameroon.
This was a retrospective cohort study including 420 patients referred for CKD between 2006 and 2012 to the nephrology unit of the Douala General Hospital in the littoral region of Cameroon. Their disease and risk profile was assessed at baseline and every 3 months for 1 year. Estimated glomerular filtration rate (eGFR) was based on MDRD and Schwartz equations. CKD was diagnosed in the presence of eGFR< 60 ml/min/1.73 m and/or proteinuria> 1+ and/or abnormal renal ultrasound persisting for ≥3 months. Data analysis used mixed linear regressions.
Of the 420 patients included, 66.9% were men and mean age was 53.8 (15.1) years. At referral, 37.5% of the participants were at CKD Stage 3, 30.8% at stage 4 and 26.8% at stage 5. There was 168 (40%) diabetic and 319 (75.9%) hypertensive patients. After some improvement during the first 3 months, eGFR steadily decreased during the first year of follow-up, and this pattern was robust to adjustment for many confounders. Systolic and diastolic blood pressure levels significantly fluctuated during the first twelve months of follow-up. Changes in the levels of other risk factors and markers of disease severity over time were either borderline or non-significant.
Patients with CKD in African settings are referred to the nephrologist at advanced stages. This likely translates into a less beneficial effects of specialised care on the course of the disease.
在非洲,肾病学专家对慢性肾脏病(CKD)患者的疾病成因和风险因素的变化知之甚少。本研究旨在评估喀麦隆一家三级医院新转诊患者的 CKD 标志物基线水平及其 12 个月的时间趋势。
这是一项回顾性队列研究,纳入了 2006 年至 2012 年期间因 CKD 转诊至喀麦隆滨海地区杜阿拉综合医院肾病科的 420 例患者。在基线和 1 年内每 3 个月评估一次他们的疾病和风险状况。估算肾小球滤过率(eGFR)基于 MDRD 和 Schwartz 方程。CKD 的诊断标准为 eGFR<60ml/min/1.73m2 和/或蛋白尿>1+和/或持续>3 个月的异常肾脏超声。数据分析采用混合线性回归。
420 例患者中,66.9%为男性,平均年龄为 53.8(15.1)岁。转诊时,37.5%的患者处于 CKD 3 期,30.8%处于 4 期,26.8%处于 5 期。有 168 例(40%)糖尿病患者和 319 例(75.9%)高血压患者。在最初 3 个月有所改善后,eGFR 在随访的第一年中稳步下降,这种模式在调整了许多混杂因素后仍然稳健。收缩压和舒张压水平在随访的前 12 个月内显著波动。随着时间的推移,其他风险因素和疾病严重程度标志物的水平变化要么是边缘的,要么是没有统计学意义的。
非洲环境下的 CKD 患者在疾病晚期才被转诊给肾病专家。这可能意味着专科护理对疾病进程的益处较小。